Generics Industry News Search
 |
|
|
|
|
|
|
November 2014 News Archive |
|
|
| |
|
The Commerce and Industry Ministry is looking into the merit of Cipla's demand for revocation of patents of Novartis for respiratory drug Indacaterol...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Breckenridge announces the approval of Quetiapine fumarate tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lupin announced today that it has received final approval for its Celecoxib capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IDT Australia has arranged to acquire a portfolio of 23 marketed generic drug products for up to US$18 million ($20.7 million)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The patent provisions of the Hatch-Waxman Act are familiar to both sides of the branded-generic fence by now...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark Generics has been granted final approval for its ANDA from the U.S. FDA for Omeprazole delayed release capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the U.S. launch of its Norethindrone acetate and Ethinyl oestradiol tablets USP, 1 mg/0.02 mg and Ferrous fumarate...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories announced today that the company has received approval from the U.S. FDA to manufacture and market Fenofibrate capsules USP...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In a relief to the US pharma major Pfizer, The Intellectual Property Appellate Board (IPAB) has set aside the Assistant Controller of Patents and Designs order, which rejected the Patent Application the pharma company for a drug Tofacitineb treating rheumatoid arthritis...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
ANI today announced the launch of Methazolamide...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo announced today that it has reinitiated shipments of Guaifenesin...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. FDA said it has granted final approval to Indian drugmaker Dr Reddy's Laboratories and U.S. firm Endo International to make cheaper copies of Roche Holding AG's antiviral Valcyte...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. FDA has revoked a tentative approval for India's Ranbaxy Laboratories to make a cheap copy of AstraZeneca's heartburn drug Nexium...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ipsos Healthcare has announced the launch of its syndicated Biosimilar Impact Study...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Drug firm Venus Remedies has received approval from the Swiss drug authority to market its generic injectable antibiotic Meropenem used for treating infections in the country...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announced the availability of a new 5mg strength of Dexmethylphenidate HCl extended-release (ER) Capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sucampo Pharmaceuticals announced that it, together with R-Tech Ueno, Sucampo AG, and Takeda and certain affiliates of Takeda, have filed a patent infringement lawsuit against Dr. Reddy's...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Horizon today announced that a favorable Markman ruling has been issued...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis is in talks to acquire Allergan for at least $60 billion, and striving to reach a deal that would help the Botox maker rebuff Valeant Pharmaceuticals' hostile advances...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Chicago-based AbbVie and Foster City, California-based Gilead are trading lawsuits...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mallinckrodt has been informed by the FDA that the agency has reason to believe that the company's Methylphenidate hydrochloride...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Kremers Urban Pharmaceuticals (KU) has been informed by the U.S. FDA that the agency requests an additional bioequivalence study...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In the race to commercialise a new class of potential cardiovascular blockbusters, Amgen and its team of lawyers have filed a patent suit to fend off the advance of rivals Sanofi and Regeneron...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Canada, announced today that Health Canada has approved its application for the generic version of Celebrex for the symptomatic relief associated with osteoarthritis...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories has sued the U.S. FDA for revoking approvals granted to the Indian firm to launch copies of two drugs including AstraZeneca's heartburn pill Nexium, court documents showed...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Australia-based drug giant, Mayne Pharm has reportedly filed an application seeking rights to produce and market the generic version of Pfizer's heart medication-Tikosyn...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Indian government is divided about whether to break a patent on a Bristol-Myers Squibb cancer drug...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Generic drug major Sun Pharma has recalled about 68,000 bottles of its anti-depressant Venlafaxine hydrochloride...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Vanc Pharmaceuticals is pleased to announce that it has received Notice of Compliance...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
STADA Arzneimittel AG and the biotech specialist mAbxience have agreed to negotiate over the in-licensing of an Adalimumab (Humira) biosimilar
...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A controversial new rule for updating generic drug labelling that the FDA was expected to finalise next month will not be published until the fall of 2015...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mallinckrodt confirmed that on November 17, 2014 it filed a lawsuit against the FDA...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories lost a bid for a temporary court order to block rivals' generic versions of the heartburn pill Nexium and the antiviral drug Valcyte...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's Laboratories announced today that it has launched its over-the-counter (OTC) Fexofenadine hydrochloride and Pseudoephedrine hydrochloride extended release tablets 60 mg / 120 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Endo International today announced that its Qualitest subsidiary has launched a generic version of Hoffmann-La Roche's Valcyte...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Intellipharmaceutics a pharmaceutical company specialising in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Supernus Pharmaceuticals, announced that it sued generic drug makers Zydus Pharmaceuticals and Cadila Healthcare for infringement of three patents covering its antiepileptic drug Trokendi XR...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it has filed with the FDA an ANDA for Testosterone undecanoate injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it has agreed to market the authorised generic version of Astellas' Protopic ointmen...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's announced today that it has launched Docetaxel injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IGI today announced it has submitted an ANDA to the FDA...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Medac Pharm, today announced that it has filed a motion for a preliminary injunction against Antares Pharm, to prohibit sales of the 15, 20 and 25 mg doses...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Novartis announced today that the US FDA has extended their priority
review period by up to three months for the new drug application (NDA)
of LBH589 (Panobinostat) in combination with Bortezomib and
Dexamethasone for patients with previously treated multiple myeloma...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today confirmed that it and several subsidiaries have been sued by Baxter, in connection with the filing of an ANDA with the U.S. FDA for Esmolol HCl in sodium chloride injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mallinckrodt said today that the U.S. District Court for the District of Maryland, Greenbelt Division, has denied its motion for a temporary restraining order against...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
VIVUS today announced that the U.S. PTO has issued U.S. Patent Nos. 8,895,057, covering methods for effecting weight loss using Qsymia, and 8,895,058, covering compositions of Qsymia...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Drug firm Ranbaxy Laboratories today said the DC Federal Court in the US has not granted the company temporary restraining order to block the US health regulator from approving...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IntelGenx today announced that it has settled its Paragraph IV litigation with Wockhardt Bio related to...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Nippon Kayaku today launches the sale of Infliximab BS for I.V. Infusion...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
